Our COO/CSO, Karen Wen was invited at Taiwan HSCT & Cell Therapy Congress 2024 in NTUH, Taiwan (July 13, 2024)2024-07-16Our Founder/CEO/CSO, Sareina Wu, and BD Director, Ting-Wan, will present as an invited expert speaker at 7th Annual CAR-TCR Summit Europein London, UK (February27-29, 2024)2024-01-29 GenomeFrontier’s non-viral Quantum pBac was featured in an Genetic Engineering and Biotechnology News article on Streamlining CAR/TCR-T Therapy Manufacturing (April 23, 2024) For more information: https://www.genengnews.com/topics/cancer/streamlining-car-tcr-t-therapy-manufacturing/ Share0